TCL Archive New Staff Proposals For Comprehensive Center Recognition Considered By NCAB January 19, 1979
TCL Archive Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says February 13, 1998
TCL Archive NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal. February 3, 2006
TCL Archive Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer July 11, 2014
